Evaluating the reduction of elective radiotherapy fields for de novo metastatic nasopharyngeal carcinoma in the immunotherapy era

Ähnliche Einträge

• Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers
  von: Li Ma, et al.
  Veröffentlicht: (2024)
• Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
  von: Zikun Yu, et al.
  Veröffentlicht: (2024)
• Mecapegfilgrastim for the prophylaxis of chemotherapy‐induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study
  von: Qifeng Jin, et al.
  Veröffentlicht: (2024)
• The prevalence of gastroesophageal reflux disease and laryngopharyngeal reflux in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma
  von: Peter K. M. Ku, et al.
  Veröffentlicht: (2024)
• Higher area deprivation index is associated with poorer local control and overall survival in non‐metastatic nasopharyngeal carcinoma
  von: Nauman H. Malik, et al.
  Veröffentlicht: (2024)